RE: READ BETWEEN THE LINES.13 Mar 2025 18:11
January 9th 2025
"This breakthrough research confirms our confidence in P140, its future therapeutic success and also creates potential new opportunities to strengthen our intellectual property portfolio, positioning us at the forefront of innovation in autoimmune disease therapies."
March 13 2025
"P140 has a unique MOA: The results provide direct evidence for the first time of a major key hypothesis of the unique MOA of P140".
"P140 is non-immunosuppressive: Unlike the most advanced therapies currently available for the treatment of autoimmune diseases, these findings indicate that P140 does not reduce or block the body's ability to mount a specific immune response".
"P140 is effective and safe: These findings confirm P140's potential as a safe and effective treatment for patients suffering from systemic lupus erythematosus" (SLE).
MORE DETAILS TO BE FORWARDED IN DUE COURSE.